ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

INF Informa Plc

803.80
9.40 (1.18%)
Last Updated: 15:02:22
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Informa Plc LSE:INF London Ordinary Share GB00BMJ6DW54 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  9.40 1.18% 803.80 803.60 804.00 804.20 795.40 800.20 435,483 15:02:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Periodical:pubg,pubg & Print 3.28B 419M 0.2986 26.76 11.21B

Informa PLC Disposal of Life Sciences Media Brands Portfolio (7562O)

01/02/2019 7:00am

UK Regulatory


Informa (LSE:INF)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Informa Charts.

TIDMINF

RNS Number : 7562O

Informa PLC

01 February 2019

Press Release

1 February 2019

Informa PLC

Divestiture of Life Sciences Media Brands Portfolio

Continued Progressive Portfolio Management ("PPM")

London: Informa (LSE: INF.L), the International Exhibitions, Events, Business Intelligence and Academic Publishing Group, today announces the divestiture of the Life Sciences Media Brands Portfolio that was previously part of UBM plc, to MJH Associates, a leading US-based, independent full-service healthcare education, market research and multi-channel medical communications company, for a consideration of just over $100m.

This forms part of Informa's PPM programme launched post the combination with UBM plc. This programme will increase the focus on businesses and Brands with strong market positions in core verticals, where the enlarged Informa portfolio is committed to future growth and scale.

The transaction does not include the CBI events business, which has been combined with the branded Life Sciences business within the Knowledge & Networking Division of Informa. The businesses being acquired by MJH are a portfolio of Life Science Media Brands that were previously reported within Other Marketing Services by UBM. These brands generate revenue largely through a mix of advertising and sponsorship, and cover three core vertical markets: Healthcare, (including brands such as Medical Economics, Practical Cardiology, Dermatology Times), Pharma (LC/GC, Pharmaceutical Technology, Spectroscopy, BioPharm International), and Animal Health (DVM360, Vetted, Firstline).

 
Enquiries 
Informa PLC 
Stephen A. Carter, Group Chief Executive              +44 (0) 20 7017 5771 
Gareth Wright, Group Finance Director                 +44 (0) 20 7017 7096 
Richard Menzies-Gow, Director of Investor Relations   +44 (0) 20 3377 3445 
Teneo Strategy 
Tim Burt / Zoe Watt                                   +44 (0) 20 7240 2486 
----------------------------------------------------  -------------------- 
 

Notes to editors

Informa Group PLC

Informa is a leading international Exhibitions, Events, Information Services and Scholarly Research Group with annual revenues approaching GBP3 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com.

MJH Associates, Inc

MJH is the largest privately held, independent full-service medical media company in the US dedicated to delivering trusted healthcare knowledge across multiple channels. Over 600 MJH professionals are dedicated to providing accessible and engaging information to diverse healthcare professionals, patients and caregivers to optimize health outcomes. The company combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and custom market research with the customer service focus and customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit http://www.mjhassoc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DISEAPFFDFKNEFF

(END) Dow Jones Newswires

February 01, 2019 02:00 ET (07:00 GMT)

1 Year Informa Chart

1 Year Informa Chart

1 Month Informa Chart

1 Month Informa Chart

Your Recent History

Delayed Upgrade Clock